Mapping the Safety Profile of BiologicalsA Disproportionality Analysis Using the WHO Adverse Drug Reaction Database, VigiBase

被引：0

作者：

Thijs J. Giezen

Aukje K. Mantel-Teeuwisse

Ronald H.B. Meyboom

Sabine M.J.M. Straus

Hubert G.M. Leufkens

Toine C.G. Egberts

机构：

[1] Utrecht University,Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology

[2] Medicines Evaluation Board,WHO Collaborating Centre for International Drug Monitoring

[3] Uppsala Monitoring Centre,Department of Clinical Pharmacy

[4] University Medical Center Utrecht,undefined

来源：

Drug Safety | 2010年 / 33卷

关键词：

Infliximab; Etanercept; Adalimumab; Teriparatide; System Organ Class;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Background: Biologicals have specific characteristics, as compared with the small molecule drugs, and carry specific risks. Safety problems, for example infliximab and the risk for tuberculosis, have been identified via spontaneous reports of suspected adverse drug reactions (ADRs). However, in general there is limited data on the nature of spontaneously reported suspected ADRs for biologicals.

引用

页码：865 / 878

页数：13

共 50 条

[41] Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
Montastruc, Jean-Louis
Sommet, Agnes
Bagheri, Haleh
Lapeyre-Mestre, Maryse
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (06) : 905 - 908
[42] Disproportionality Analysis of Stomatitis Associated with Anticancer Drugs Using the Japanese Adverse Drug Event Report Database
Hosonaka, Kousuke
Yamaoka, Kenta
Ikeda, Naoe
Uchida, Mayako
Uesawa, Yoshihiro
Takahashi, Kazushige
Shimizu, Tadashi
ONCOLOGY, 2024, 102 (09)
[43] Disproportionality analysis of amenamevir-induced encephalopathy using the Japanese adverse drug event report database
Yamada, Tomoyuki
Ogawa, Taku
Tanaka, Tomoko
Kusaka, Yusuke
Nishihara, Masami
Ashida, Akira
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2025, 31 (01)
[44] Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions
Bonaldo, Giulia
Andriani, Luisa Anna
D'Annibali, Ottavio
Motola, Domenico
Vaccheri, Alberto
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (11) : 1457 - 1463
[45] Correction to: Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBase
Emilie Patras de Campaigno
Inès Kebir
Jean-Louis Montastruc
Manuela Rueter
Delphine Maret
Maryse Lapeyre-Mestre
Brigitte Sallerin
Fabien Despas
Drug Safety, 2018, 41 : 827 - 827
[46] Disproportionality Analysis of Hepatotoxic and Gastrointestinal Adverse Events Associated With Nintedanib Using the Japanese Adverse Drug Event Report (JADER) Database
Fujiwara, Masaki
Ikesue, Hiroaki
Yamaoka, Kenta
Uchida, Mayako
Uesawa, Yoshihiro
Muroi, Nobuyuki
Shimizu, Tadashi
IN VIVO, 2025, 39 (01): : 396 - 403
[47] A Disproportionality Analysis of the Adverse Effect Profiles of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Using the Japanese Adverse Drug Event Report Database
Arai, Masanori
Tsuno, Takahiro
Konishi, Hiromi
Nishiyama, Kuniyuki
Terauchi, Yasuo
Inoue, Ryota
Shirakawa, Jun
THYROID, 2023, 33 (07) : 804 - 816
[48] Who's At Risk? Identifying Risk Groups for Adverse Drug Reactions Using Vigibase
Aoki, Y.
Sandberg, L.
Taavola, H.
Chandler, R.
Noren, G. N.
DRUG SAFETY, 2018, 41 (11) : 1142 - 1143
[49] Drug-Induced Progressive Multifocal Leukoencephalopathy: A Comprehensive Analysis of the WHO Adverse Drug Reaction Database
Melis, Mauro
Biagi, Chiara
Smabrekke, Lars
Nonino, Francesco
Buccellato, Elena
Donati, Monia
Vaccheri, Alberto
Motola, Domenico
CNS DRUGS, 2015, 29 (10) : 879 - 891
[50] Blood glucose related adverse drug reaction of antitumor monoclonal antibodies: a retrospective analysis using Vigibase
Yang, Jincheng
Zhao, Bin
Zhou, Haiyan
Jia, Bei
Chen, Lianzhen
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 58

← 1 2 3 4 5 →